892 filings
Page 4 of 45
4
CPRX
Catalyst Pharmaceuticals Inc
12 Dec 23
CATALYST PHARMACEUTICALS / PATRICK J MCENANY ownership change
5:00pm
4
Preethi Sundaram
12 Dec 23
CATALYST PHARMACEUTICALS / Preethi Sundaram ownership change
5:00pm
4
Molly Harper
12 Dec 23
CATALYST PHARMACEUTICALS / Molly Harper ownership change
5:00pm
4
Tamar Thompson
12 Dec 23
CATALYST PHARMACEUTICALS / Tamar Thompson ownership change
5:00pm
4
Carmen Jeffrey Del
12 Dec 23
CATALYST PHARMACEUTICALS / Carmen Jeffrey Del ownership change
5:00pm
144
Tierney David S
12 Dec 23
Notice of proposed sale of securities
2:21pm
4
Richard J Daly
11 Dec 23
CATALYST PHARMACEUTICALS / Richard J Daly ownership change
5:00pm
144
Alicia Grande
11 Dec 23
Notice of proposed sale of securities
2:57pm
144
Alicia Grande
11 Dec 23
Notice of proposed sale of securities
12:54pm
4
CPRX
Catalyst Pharmaceuticals Inc
8 Dec 23
CATALYST PHARMACEUTICALS / GARY INGENITO ownership change
5:00pm
S-8
CPRX
Catalyst Pharmaceuticals Inc
8 Dec 23
Registration of securities for employees
4:31pm
S-8
CPRX
Catalyst Pharmaceuticals Inc
8 Dec 23
Registration of securities for employees
4:31pm
144
Alicia Grande
8 Dec 23
Notice of proposed sale of securities
4:14pm
4
Steve Miller
7 Dec 23
CATALYST PHARMACEUTICALS / Steve Miller ownership change
5:00pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
7 Dec 23
Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions
4:30pm
144
Gary Ingenito
6 Dec 23
Notice of proposed sale of securities
12:48pm
144
Steve Miller
5 Dec 23
Notice of proposed sale of securities
4:46pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
8 Nov 23
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update
4:35pm
10-Q
2023 Q3
CPRX
Catalyst Pharmaceuticals Inc
Quarterly report
8 Nov 23
4:06pm
8-K
CPRX
Catalyst Pharmaceuticals Inc
3 Nov 23
New Patents Further Reinforce the FIRDAPSEĀ® (amifampridine) Intellectual Patent Portfolio
4:30pm